About
- About Avecho
- Board & Leadership
TPM^® Technology
Portfolio
Invest
- Investor Centre
- Media Centre
Contact

Hit enter to search or ESC to close

Receipt of R&D Tax Incentive

March 1, 2017

Click here to read more

Post navigation

Phosphagenics Full Year Financial Results

Phosphagenics Newsletter March 2017

Related Posts

Voluntary Withdrawal from OTCQX

December 3, 2018

Phosphagenics Still Awaits SIAC Arbitration Update

June 8, 2018

CEO Quarterly Update

March 1, 2017

Recent Posts

MEDIA | Hand it to cannabis
May 5, 2022
Quarterly Activities Report and 4C to 31 March 2022
April 29, 2022
Positive Results for Phase II Topical CBD Osteoarthritis Study
March 29, 2022

Categories

Analyst Coverage
Company Announcement
Company Report
Media Coverage
Newsletter
Press Release
Uncategorised

About us

We see a future where more patients can get even more from their treatments through innovative delivery technologies.

Stay Posted

Stay informed about our latest news and developments.

Leave this field empty if you're human:

About Avecho

TPM^® Technology

Portfolio

Investor Centre
- Investor Centre
- Media Centre

© Copyright 2019 Avecho Biotechnology Ltd.